Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification

OBJECTIVES: To recalibrate and validate the European Randomized Study of Screening for Prostate Cancer risk calculators (ERSPC RCs) 3/4 and the magnetic resonance imaging (MRI)‐ERSPC‐RCs to a contemporary Norwegian setting to reduce upfront prostate multiparametric MRI (mpMRI) and prostate biopsies....

Descripción completa

Detalles Bibliográficos
Autores principales: Davik, Petter, Remmers, Sebastiaan, Elschot, Mattijs, Roobol, Monique J., Bathen, Tone Frost, Bertilsson, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
To the Clinic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349589/
https://www.ncbi.nlm.nih.gov/pubmed/35950035
http://dx.doi.org/10.1002/bco2.146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349589/
https://www.ncbi.nlm.nih.gov/pubmed/35950035
http://dx.doi.org/10.1002/bco2.146

Ejemplares similares